Business Description
Gaush Meditech Ltd
ISIN : KYG3902N1051
Compare
Compare
Traded in other countries / regions
02407.Hong KongF7Y.Germany IPO Date
2022-12-12Description
Gaush Meditech Ltd is a provider of a broad spectrum of ophthalmic medical devices. The segments of the company include 1) Proprietary products segment develops and produces surgical equipment and related supporting software, intra-optical lens, ophthalmic disease diagnosis and treatment equipment and related supporting consumables independently; 2) Distribution products segment sells multi-function diagnostic equipment, ocular fundus diagnosis, surgical and treatment equipment and related supporting consumables produced by ophthalmic medical equipment manufacturers; 3) Technical services segment provides warranty services, maintenance services and after-sales services related consumables; and 4) Others segment.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.21 | |||||
| Equity-to-Asset | 0.55 | |||||
| Debt-to-Equity | 0.41 | |||||
| Debt-to-EBITDA | 2.13 | |||||
| Interest Coverage | 4.36 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 1.54 | |||||
| Beneish M-Score | -2.58 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 10.5 | |||||
| 3-Year EBITDA Growth Rate | 28 | |||||
| 3-Year EPS without NRI Growth Rate | 3.8 | |||||
| 3-Year FCF Growth Rate | 13.5 | |||||
| 3-Year Book Growth Rate | 292.8 | |||||
| Future 3-5Y Total Revenue Growth Rate | 8.35 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 54.44 | |||||
| 9-Day RSI | 52.45 | |||||
| 14-Day RSI | 51.92 | |||||
| 6-1 Month Momentum % | -37.93 | |||||
| 12-1 Month Momentum % | -70.68 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.87 | |||||
| Quick Ratio | 1.38 | |||||
| Cash Ratio | 1.02 | |||||
| Days Inventory | 170.98 | |||||
| Days Sales Outstanding | 40.66 | |||||
| Days Payable | 50.64 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 10.24 | |||||
| Dividend Payout Ratio | 1.66 | |||||
| Forward Dividend Yield % | 10.24 | |||||
| 5-Year Yield-on-Cost % | 10.24 | |||||
| Shareholder Yield % | 20.01 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 47.08 | |||||
| Operating Margin % | 15.41 | |||||
| Net Margin % | 6.75 | |||||
| FCF Margin % | 6.05 | |||||
| ROE % | 5.62 | |||||
| ROA % | 3.2 | |||||
| ROIC % | 5.62 | |||||
| ROC (Joel Greenblatt) % | 94.4 | |||||
| ROCE % | 10.58 | |||||
| Years of Profitability over Past 10-Year | 2 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 16.17 | |||||
| Forward PE Ratio | 8.9 | |||||
| PE Ratio without NRI | 16.17 | |||||
| Price-to-Owner-Earnings | 7.18 | |||||
| PS Ratio | 1.13 | |||||
| PB Ratio | 0.96 | |||||
| Price-to-Tangible-Book | 4.15 | |||||
| Price-to-Free-Cash-Flow | 17.94 | |||||
| Price-to-Operating-Cash-Flow | 11.43 | |||||
| EV-to-EBIT | 6.31 | |||||
| EV-to-EBITDA | 4.59 | |||||
| EV-to-Revenue | 0.99 | |||||
| EV-to-FCF | 14.83 | |||||
| Price-to-Graham-Number | 1.73 | |||||
| Price-to-Net-Current-Asset-Value | 12.34 | |||||
| Earnings Yield (Greenblatt) % | 15.85 | |||||
| FCF Yield % | 5.57 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Gaush Meditech Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 1,462.877 | ||
| EPS (TTM) (HK$) | 0.664 | ||
| Beta | 0 | ||
| Volatility % | 41.76 | ||
| 14-Day RSI | 51.92 | ||
| 14-Day ATR (HK$) | 0.818051 | ||
| 20-Day SMA (HK$) | 10.6595 | ||
| 12-1 Month Momentum % | -70.68 | ||
| 52-Week Range (HK$) | 8.45 - 42.05 | ||
| Shares Outstanding (Mil) | 147.89 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Gaush Meditech Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Gaush Meditech Ltd Stock Events
| Event | Date | Price(HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Gaush Meditech Ltd Frequently Asked Questions
What is Gaush Meditech Ltd(HKSE:02407)'s stock price today?
The current price of HKSE:02407 is HK$10.74. The 52 week high of HKSE:02407 is HK$42.05 and 52 week low is HK$8.45.
When is next earnings date of Gaush Meditech Ltd(HKSE:02407)?
The next earnings date of Gaush Meditech Ltd(HKSE:02407) is .
Does Gaush Meditech Ltd(HKSE:02407) pay dividends? If so, how much?
The Dividend Yield %  of Gaush Meditech Ltd(HKSE:02407) is 10.24% (As of Today), Highest Dividend Payout Ratio of Gaush Meditech Ltd(HKSE:02407) was 1.66. The lowest was 0. And the median was 0. The  Forward Dividend Yield % of Gaush Meditech Ltd(HKSE:02407) is 10.24%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers